70.22.Z - Business and other management consultancy activities
46.90.Z - Non-specialised wholesale trade
47.78.Z - Other retail sale of new goods in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 2,7 | -2,1 | 7,7 | 473,9 |
EBITDA | -8 | -7,6 | -7,8 | -3 |
Short time liabilities | 0 | 0 | 0 | 0 |
Equity capital | 133,6 | 131,5 | 139,3 | 5,9 |
Operating profit (EBIT) | -8 | -7,6 | -7,8 | -3 |
Assets | 133,6 | 131,5 | 139,3 | 5,9 |
Net profit (loss) | 2,7 | -2,1 | 7,7 | 473,9 |
Cash | 5,9 | 3,8 | 11,6 | 200,9 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 0 |
Working assets | 5,9 | 3,8 | 11,6 | 200,9 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 2 | -1,6 | 5,6 | 7,2 |
Equity capital to total assets | 100 | 100 | 100 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 0 | 0 |
Current financial liquidity indicator | 1,6 | |||
Net dept to EBITDA | 0.7438675165176392 | 0.5054792761802673 | 1.476430058479309 | 1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane